-
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
24 Apr 2024 20:05 GMT
… call. About Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals is a biopharmaceutical … neuroscience portfolio includes approved treatments for epilepsy, migraine, ADHD … PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal …
-
Levodopa Market to Reach $2.9 Billion Globally By 2032 at 6.1% CAGR: Allied Market Research
23 Apr 2024 12:40 GMT
…
Technological advancements in drug delivery Development of … infrastructure and advanced medical research facilities in … of novel levodopa formulations and treatment approaches, driving … Myers Squibb Co.
Sun Pharmaceutical Industries Ltd.
Pfizer …
-
AbbVie, NeuroDerm Heat Up Levodopa Competition with New Data at AAN24
22 Apr 2024 17:39 GMT
Pictured: Doctor looking at a patient' … of prodrugs of levodopa and carbidopa, respectively—for the treatment of motor … . In March 2023, the FDA hit the drug candidate with a Complete … of a head-to-head trial.”
Tristan Manalac is an independent …
-
Military veteran embraces ‘new service’ of helping others after his Parkinson's diagnosis : ‘There is hope'
22 Apr 2024 09:25 GMT
… started taking Levodopa, a central nervous system drug that helps … Engineering, and Medicine released a report stating that there is … toward improved Parkinson’s treatments and a future cure. … therapist, religious leaders, doctors, physical therapists or a …
-
Cerevel reports positive data from Phase III Parkinson’s treatment trial
19 Apr 2024 09:52 GMT
… of tavapadon as an adjunctive treatment to levodopa (LD) in 507 adult … the trial were mild to moderate in severity.
Cerevel Therapeutics chief medical … this year from the monotherapy trials, TEMPO-1 and TEMPO-2 …
-
Cerevel's Parkinson's disease drug improves symptom control in late-stage trial
19 Apr 2024 02:04 GMT
… its Parkinson's disease drug improved symptom control in patients … the trial.
The patients were on a stable dose of levodopa for … from late-stage trials testing the once-daily treatment tavapadon as a …
-
Early Data Indicate Cell Therapies Could ‘Reset the Clock’ in Parkinson’s
22 Apr 2024 11:47 GMT
… treatment for Parkinson’s. Although it provides a dopamine kick, the drug … Wong said early clinical trials of stem cell … trial, patients’ ON-Time—a period where Parkinson’s medications like levodopa … the environment, biotechnology and life sciences.
-
Cerevel’s Tavapadon Meets Primary End Point in Phase 3 TEMPO-3 Study of Parkinson Disease
20 Apr 2024 20:36 GMT
… treatment for PD.1
All told, when used as adjunctive to levodopa … ; Raymond Sanchez, MD, chief medical officer, Cerevel Therapeutics, said in … this year from the monotherapy trials, TEMPO-1 and TEMPO- … in phase 3 adjunctive trial for people living with …
-
Parkinson Gene Therapy AB-1005 Continues to Show Promising Results at 18 Months
19 Apr 2024 17:20 GMT
… as unrelated to the study treatment. Between mild and moderate … milder disease had a lower Levodopa Equivalent Daily Dose (LEDD) … ) point improvement in ON medication state compared with baseline.
… and development at Bayer’s Pharmaceuticals Division, said in a …
-
AAN 2024: Pharma Two B’s P2B001 shows promise in early PD
19 Apr 2024 15:46 GMT
… , a consequence of long-term levodopa treatment.
Key opinion leaders (KOLs) previously … -concentration drugs in a single pill, it will slightly lessen the pill burden … AAN 2024 ‘Movement Disorders: Clinical Trials in Movement Disorders’ presentation, Pharma …